US 11479602
Methods of treating C5-associated diseases comprising administering anti-C5 antibodies
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 11479602 (Methods of treating C5-associated diseases comprising administering anti-C5 antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K39/3955, A61K45/06